We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

194 hedge funds and large institutions have $4.37B invested in NEVRO CORP. in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 61 increasing their positions, 72 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less funds holding

Funds holding: 207194 (-13)

13% less call options, than puts

Call options by funds: $32.9M | Put options by funds: $37.7M

15% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 72

24% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 46

31% less capital invested

Capital invested by funds: $6.36B → $4.37B (-$1.99B)

Holders
194
Holders Change
-13
Holders Change %
-6.28%
% of All Funds
3.4%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
35
Increased
61
Reduced
72
Closed
46
Calls
$32.9M
Puts
$37.7M
Net Calls
-$4.8M
Net Calls Change
-$9.11M
Name Holding Trade Value Shares
Change
Change in
Stake
N
76
Natixis
France
$3.36M -$6.02M -46,000 -61%
Wells Fargo
77
Wells Fargo
California
$3.34M -$973K -7,437 -21%
JRP
78
Jasper Ridge Partners
California
$3.03M
Ameriprise
79
Ameriprise
Minnesota
$2.96M -$10.3M -78,474 -76%
New York State Common Retirement Fund
80
New York State Common Retirement Fund
New York
$2.92M -$642K -4,902 -16%
EVM
81
Eaton Vance Management
Massachusetts
$2.86M
State of New Jersey Common Pension Fund D
82
State of New Jersey Common Pension Fund D
New Jersey
$2.82M +$668K +5,100 +27%
ETC
83
Exchange Traded Concepts
Oklahoma
$2.81M +$776K +5,931 +33%
MOACM
84
Mutual of America Capital Management
New York
$2.65M -$802K -6,130 -21%
JG
85
Jefferies Group
New York
$2.58M +$1.55M +11,864 +115%
Prudential Financial
86
Prudential Financial
New Jersey
$2.46M -$17.9K -137 -0.6%
Marshall Wace
87
Marshall Wace
United Kingdom
$2.45M +$2.75M +21,020 New
Bank of Montreal
88
Bank of Montreal
Ontario, Canada
$2.33M +$1.6M +12,207 +165%
Wolverine Trading
89
Wolverine Trading
Illinois
$2.27M +$2.54M +19,399 New
E
90
Ergoteles
New York
$2.21M +$1.28M +9,773 +106%
SCF
91
Sante Capital Fund
Texas
$2.21M +$2.48M +18,963 New
AIG
92
American International Group
New York
$2.2M -$59K -451 -2%
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.06M -$205K -1,567 -8%
DWT
94
Dorsey & Whitney Trust
South Dakota
$1.91M
SG Americas Securities
95
SG Americas Securities
New York
$1.86M +$635K +4,855 +44%
OAM
96
Oppenheimer Asset Management
New York
$1.78M -$72.9K -557 -4%
DA
97
Duality Advisers
Florida
$1.73M +$1.95M +14,898 New
AQR Capital Management
98
AQR Capital Management
Connecticut
$1.72M +$928K +7,086 +93%
Squarepoint
99
Squarepoint
New York
$1.63M +$121K +925 +7%
State Board of Administration of Florida Retirement System
100
State Board of Administration of Florida Retirement System
Florida
$1.63M +$52.4K +400 +3%

NVRO Hedge Fund Activity: Q3 2021 in Review

194 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2021, worth a combined $4.37B — down 31% from $6.36B a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of NVRO and 35 opened new positions — a net loss of 11 holders — while 72 trimmed existing stakes and 61 added.

The largest buyer was Jackson Square Partners, adding an estimated $127M. The largest seller was Fred Alger Management, cutting an estimated $165M.

  • 194 institutional investors held NEVRO CORP. (NVRO) as of Q3 2021, down from 207 in Q2 2021.
  • Funds reported $4.37B of NEVRO CORP. stock for Q3 2021, down 31% quarter-over-quarter.
  • 35 funds opened new NEVRO CORP. positions in Q3 2021 and 46 closed out, a net change of -11 holders.
  • The largest NEVRO CORP. buyer in Q3 2021 was Jackson Square Partners, an estimated $127M added.
  • The largest NEVRO CORP. seller in Q3 2021 was Fred Alger Management, an estimated $165M sold.

Based on aggregated 13F filings for Q3 2021.